Vaneck Pharmaceutical Etf Price History

PPH Etf  USD 90.01  0.61  0.68%   
Below is the normalized historical share price chart for VanEck Pharmaceutical ETF extending back to February 01, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of VanEck Pharmaceutical stands at 90.01, as last reported on the 28th of November, with the highest price reaching 90.26 and the lowest price hitting 89.58 during the day.
3 y Volatility
14.38
200 Day MA
91.671
1 y Volatility
12.49
50 Day MA
92.518
Inception Date
2011-12-20
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in VanEck Etf, it is important to understand the factors that can impact its price. VanEck Pharmaceutical ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.22, which indicates the etf had a -0.22% return per unit of risk over the last 3 months. VanEck Pharmaceutical ETF exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VanEck Pharmaceutical's Coefficient Of Variation of (515.17), risk adjusted performance of (0.15), and Variance of 0.4436 to confirm the risk estimate we provide.
  
VanEck Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2203

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPPH

Estimated Market Risk

 0.68
  actual daily
6
94% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.22
  actual daily
0
Most of other assets perform better
Based on monthly moving average VanEck Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Pharmaceutical by adding VanEck Pharmaceutical to a well-diversified portfolio.
Average Mkt Cap Mil
134.7 K

VanEck Pharmaceutical Etf Price History Chart

There are several ways to analyze VanEck Pharmaceutical ETF price data. The simplest method is using a basic VanEck candlestick price chart, which shows VanEck Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 4, 202498.48
Lowest PriceNovember 15, 202486.59

VanEck Pharmaceutical November 28, 2024 Etf Price Synopsis

Various analyses of VanEck Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell VanEck Etf. It can be used to describe the percentage change in the price of VanEck Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of VanEck Etf.
VanEck Pharmaceutical Accumulation Distribution 1,365 
VanEck Pharmaceutical Price Rate Of Daily Change 1.01 
VanEck Pharmaceutical Price Daily Balance Of Power 0.90 
VanEck Pharmaceutical Price Action Indicator 0.40 

VanEck Pharmaceutical November 28, 2024 Etf Price Analysis

When benchmark price declines in a down market, there may be an uptick in VanEck Pharmaceutical ETF price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use VanEck Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in VanEck Pharmaceutical ETF and then apply it to test your longer-term investment strategies against VanEck.

VanEck Etf Price History Data

The price series of VanEck Pharmaceutical for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 12.41 with a coefficient of variation of 3.55. The price distribution for the period has arithmetic mean of 93.54. The median price for the last 90 days is 94.21. The company had dividends distributed to its stock-holders on 1st of October 2021.
OpenHighLowCloseVolume
11/27/2024 89.61  90.26  89.58  90.01  181,231 
11/26/2024 89.34  89.48  88.82  89.40  109,519 
11/25/2024 88.82  89.25  88.62  88.78  202,041 
11/22/2024 88.18  88.97  88.18  88.58  280,138 
11/21/2024 87.46  88.05  87.01  87.94  103,323 
11/20/2024 86.91  87.55  86.90  87.44  227,893 
11/19/2024 86.06  86.91  85.99  86.87  210,900 
11/18/2024 86.12  86.61  86.00  86.61  168,994 
11/15/2024 87.32  87.40  86.44  86.59  699,400 
11/14/2024 89.38  89.54  88.12  88.17  198,616 
11/13/2024 89.41  89.74  89.21  89.48  282,067 
11/12/2024 90.09  90.37  89.48  89.53  456,700 
11/11/2024 91.16  91.32  90.65  90.69  541,223 
11/08/2024 90.83  91.37  90.46  90.95  123,657 
11/07/2024 89.92  90.88  89.83  90.75  178,556 
11/06/2024 90.91  90.91  89.05  89.13  761,865 
11/05/2024 90.39  90.75  89.89  90.75  303,216 
11/04/2024 91.06  91.48  90.78  90.82  119,747 
11/01/2024 91.62  91.98  91.36  91.39  114,373 
10/31/2024 91.07  91.60  90.81  91.31  447,173 
10/30/2024 90.35  91.91  89.54  91.91  292,186 
10/29/2024 92.57  92.83  92.28  92.31  408,358 
10/28/2024 92.17  92.80  92.17  92.78  252,548 
10/25/2024 92.84  92.84  92.00  92.14  93,045 
10/24/2024 93.29  93.29  92.43  92.47  66,137 
10/23/2024 93.30  93.49  92.90  93.23  57,490 
10/22/2024 93.12  93.70  93.00  93.59  243,170 
10/21/2024 94.49  94.69  93.59  93.63  48,284 
10/18/2024 94.44  94.79  94.04  94.67  108,977 
10/17/2024 94.77  94.92  94.51  94.51  98,916 
10/16/2024 94.47  94.97  94.33  94.80  44,666 
10/15/2024 94.31  95.27  94.18  94.65  124,963 
10/14/2024 94.47  94.72  94.22  94.57  75,290 
10/11/2024 94.18  94.28  93.90  94.21  63,700 
10/10/2024 94.54  94.54  93.61  93.78  273,722 
10/09/2024 93.46  94.40  93.17  94.33  162,358 
10/08/2024 93.23  93.66  93.13  93.46  55,220 
10/07/2024 93.60  93.88  93.10  93.24  91,851 
10/04/2024 93.08  93.41  92.90  93.41  389,041 
10/03/2024 93.92  93.92  93.12  93.26  143,229 
10/02/2024 94.32  94.35  93.69  94.02  101,476 
10/01/2024 94.85  94.85  94.20  94.54  115,536 
09/30/2024 94.16  94.74  94.03  94.62  323,359 
09/27/2024 94.82  94.93  94.38  94.43  204,615 
09/26/2024 94.71  95.02  94.46  94.92  157,060 
09/25/2024 95.81  96.01  94.90  94.97  169,442 
09/24/2024 95.58  95.78  95.04  95.59  127,210 
09/23/2024 95.84  95.85  95.46  95.66  79,050 
09/20/2024 96.43  96.43  95.75  95.98  64,889 
09/19/2024 97.33  97.33  96.44  96.76  101,325 
09/18/2024 97.06  97.44  96.60  96.73  155,261 
09/17/2024 97.61  97.61  96.44  96.82  213,284 
09/16/2024 97.46  97.88  97.46  97.88  51,215 
09/13/2024 96.74  97.25  96.74  97.10  61,748 
09/12/2024 96.61  96.88  95.96  96.88  61,690 
09/11/2024 96.66  96.69  95.50  96.68  152,030 
09/10/2024 96.53  96.67  95.94  96.61  291,897 
09/09/2024 96.52  97.08  96.26  96.64  396,053 
09/06/2024 97.19  97.69  96.12  96.24  85,304 
09/05/2024 98.21  98.21  96.53  96.82  154,943 
09/04/2024 98.63  98.64  98.20  98.48  127,213 

About VanEck Pharmaceutical Etf history

VanEck Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for VanEck is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in VanEck Pharmaceutical ETF will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing VanEck Pharmaceutical stock prices may prove useful in developing a viable investing in VanEck Pharmaceutical

VanEck Pharmaceutical Etf Technical Analysis

VanEck Pharmaceutical technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of VanEck Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of VanEck Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Commodity Directory Now

   

Commodity Directory

Find actively traded commodities issued by global exchanges
All  Next Launch Module

VanEck Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for VanEck Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of VanEck Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of VanEck to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.